Roche Gets Long-Awaited Green Light For COVID-19 Cocktail In EU

Regulator’s Chief Intervenes To Speed Availability

Key committee was asked to fast-track a decision on the antibody cocktail, but lack of mortality data could mean patchy uptake seen in US repeated in the EU.

Roche
Roche will add the antibody cocktail to its diagnostics and acute therapy Actemra being used to tackle COVID-19.

More from Business

More from Scrip